UK-US Trade Deals: Medicines Pact & Tech Sovereignty Row
New UK-US medicines agreement aims to boost NHS access to innovative drugs, but critics warn of eroded sovereignty in wider trade pacts with Trump. Explore the debate.
Category : Search result: pharmaceutical companies
AU$33m Pharma Payments to Doctors Raise Ethics Concerns
New data reveals over 6,500 Australian doctors received payments from drug firms. Experts warn this influences prescriptions, raising serious healthcare ethics questions. Read the full investigation.
Cumberbatch sells stake in SunnyMarch production company
Benedict Cumberbatch has sold a controlling stake in his SunnyMarch production company to Lumina Studios Group. Discover the details of the deal and what it means for the future of the firm behind hits like 'The Courier'. Read the full story.
Snail Farm Tax Avoidance Scheme Exposed
A 79-year-old former shoe salesman is using snail farms in empty London offices to cheat councils out of millions in business rates. Meet the man behind Britain's most brazen tax dodge.
UK-US Pharma Deal: NHS to Pay 25% More for New Drugs
A new UK-US deal doubling spending on US medicines raises NHS funding fears. Experts warn of a 'problematic precedent' that could impact Australia and global healthcare systems.
UK-US agree zero tariff deal on pharmaceuticals
The UK has secured a major three-year deal for zero US import tariffs on pharmaceuticals, safeguarding £5bn in annual exports and boosting life sciences investment. Read the full analysis.
UK-US zero-tariff pharma deal, NHS drug price rise
The UK and US have agreed a landmark deal maintaining zero tariffs on pharmaceuticals, while the NHS commits to a 25% net price increase for new medicines. Explore the details and implications.
US and UK agree zero-tariffs on pharmaceuticals
The US has agreed to spare the UK from threatened trade tariffs on pharmaceutical products, ensuring access to latest medical breakthroughs. Read the full details.
FDA Implements Stricter Vaccine Approval Protocols
US regulator FDA announces major overhaul of vaccine approval process following COVID-19 review. New protocols aim to strengthen public trust in immunisation programmes.
Novo Nordisk shares slide after Ozempic pill fails
Novo Nordisk shares slumped over 10% after its Ozempic pill failed to slow Alzheimer's progression in major trials. Read the latest on the pharmaceutical giant's market struggles.
Nando's posts £38.2m profit after years of losses
Nando's has returned to profit for the first time since 2016 with £38.2m, but warns Rachel Reeves' tax hikes threaten future performance. Discover the full financial turnaround.
Investec Scales Up Mid-Market Business Services
Banking group Investec reveals a major push into the underserved mid-market sector, aiming to boost profitability by 200 basis points. Discover its UK and South Africa expansion plans.
Why Crypto Treasury Companies Are Bound to Struggle
New research reveals why most cryptocurrency treasury management firms face significant challenges. Discover the structural issues plaguing this emerging sector and what it means for investors.
UK Plans 25% NHS Drug Threshold Rise to End Standoff
UK ministers propose 25% increase in NHS drug cost-effectiveness thresholds to resolve investment row with pharmaceutical giants and boost life sciences sector.
Revolut boss changes name for Companies House ID rules
Revolut co-founder Nik Storonsky updates his name spelling on Companies House as new identity verification rules for directors come into force. Discover the impact.
New ID Verification Rules for UK Company Directors
From 18th November 2025, UK company directors must verify their identity with Companies House. Learn how to comply and avoid fines.
Zayn Malik One Direction Reunion Rumours Debunked
One Direction fans were sent into a frenzy by reports Zayn Malik legally rejoined the band. We investigate the Companies House facts behind the headlines and the emotional legacy of Liam Payne.
Lukoil asset fire sale ahead of US sanctions deadline
Russian oil company Lukoil faces forced divestment of international assets as US sanctions take effect November 21. Multiple countries considering nationalisation while Ukraine battles continue.
WH Ireland and Team in £20m Merger Talks
London-listed wealth managers WH Ireland and Team are in advanced all-share merger discussions, a deal that could create a combined entity with over £1.8bn in assets. Discover the implications for the UK financial sector.
NHS faces generic-only drug future warns AstraZeneca
The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.
UK businesses shrug off tax fears in growth push
New research reveals British companies are pushing forward with investment and hiring strategies despite budget uncertainties and potential tax increases, showcasing remarkable business confidence.
Novo Nordisk cuts forecasts again as drug demand slows
Danish pharmaceutical giant Novo Nordisk has cut its sales and profit forecasts for the second time in three months, sending shockwaves through the healthcare sector as demand for its blockbuster weight-loss drugs shows signs of slowing.
Water bosses lose bonuses as Ofwat cracks down
Regulator blocks executive payouts at six water companies amid public outrage over sewage spills and service failures. New rules give Ofwat power to veto bonuses.
UK phone giants unite to block scam calls
Major UK mobile providers join forces in landmark agreement to combat number spoofing fraud that costs Britons millions annually. New security measures coming 2025.
AI Gold Rush: Are Tech Valuations Defying Gravity?
As artificial intelligence companies achieve staggering multi-billion dollar valuations, experts question whether this represents genuine innovation or dangerous market speculation that could reshape global economics.
Water firms seek double charging for sewage fixes
Water companies could bill households twice for infrastructure repairs to tackle sewage pollution under new Ofwat proposals being challenged in court by environmental campaigners.
Big Pharma's Tax Breaks: Are We Getting NHS Value?
Exclusive analysis reveals pharmaceutical giants received massive tax incentives while NHS faces funding crisis. Experts demand transparency on whether these breaks are delivering promised benefits to UK healthcare.
Novo Nordisk Bids for Metsera, Challenging Pfizer's Offer
Danish pharmaceutical giant Novo Nordisk has entered a bidding war with Pfizer for obesity-focused biotech firm Metsera, potentially disrupting the US company's planned acquisition in a major power play for obesity treatment dominance.
UK Pharma Crisis: Patients Face Treatment Delays
A critical pricing dispute between the UK government and pharmaceutical companies threatens patient access to vital medicines, with industry leaders warning of treatment delays and reduced NHS access to new drugs.
GSK CEO warns UK drug pricing reforms threaten life sciences
Emma Walmsley warns Britain's life sciences industry faces 'existential threat' from proposed drug pricing reforms that could drive investment and research overseas.
Page 1 of 2